Copy

 
Athletics Veritas is a weekly series aimed at helping higher education executives, faculty, and other stakeholders stay tuned in on trending national issues impacting college athletics, especially NCAA Division I. Athletics Veritas is created by senior DI athletic administrators around the nation.

Term-in-Ology: Transgender Student-Athlete Participation

In light of proliferation of states introducing bills to regulate the participation eligibility of transgender high school athletes, the NCAA has received pressure to refrain from hosting NCAA championships in those states considering bills restricting transgender athlete participation.

As it pertains to transgender student-athlete eligibility at the collegiate level, the NCAA determined in 2015, consistent with medical treatment options and policy approved by the NCAA Board of Governors, that:

(a) A transgender male (female to male) student-athlete who has received a medical exception for treatment with testosterone for diagnosed gender dysphoria may compete on a men's team but is no longer eligible to compete on a women's team without changing that team's status to a mixed team;

(b) A transgender female (male to female) student-athlete who is being treated with testosterone suppression medication or who has undergone surgical intervention to suppress testosterone production for gender transition may continue to compete on a men's team but may not compete on a women's team without changing that team's status to a mixed team until the student-athlete has completed one year of testosterone suppression treatment or one year has passed after the surgical intervention;

(c) It is the responsibility of the institution to submit a request for a medical exception for testosterone treatment prior to allowing the student-athlete to compete while undergoing treatment. In the case of testosterone suppression, the institution is responsible for documenting hormonal or surgical suppression to meet the one year requirement and ongoing monitoring prior to a transgender female participating on a women's team without changing it to a mixed team; and

(d) For the purposes of NCAA competition, cases involving interruptions of gender dysphoria treatment will be reviewed on a case-by-case basis by the Committee on Competitive Safeguards and Medical Aspects of Sports.

The NCAA recently released this statement on transgender participation.
Veritas Archive
Term-in-ology Archive
Athletics Veritas is presented for information purposes only and should not be considered advice or counsel on NCAA compliance matters. For guidance on NCAA rules and processes, always consult your university’s athletics compliance office, conference office, and/or the NCAA.
Tweet
Share
Share
Forward

Copyright © 2021 D1.unlimited, All rights reserved.

Our mailing address is:
Athletics Veritas 
| Joe Montana | Joe MT 59336
unsubscribe from this list   update subscription preferences